PCVX · Categories · Form 4
PCVX - SEC Form 4 insider transactions
Vaxcyte Inc. (PCVX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for PCVX
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- EVP, Chief Scientific Ofc, COO Wassil Jim exercised 2,250 shares at a strike of $5.35 and sold $127,513 worth of shares (2,250 units at $56.67) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 17,056 shares, decreasing direct ownership by 4% to 429,902 units (SEC Form 4) to satisfy tax liability4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew covered exercise/tax liability with 7,155 shares, decreasing direct ownership by 7% to 95,316 units (SEC Form 4) (tax withholding)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. covered exercise/tax liability with 7,651 shares, decreasing direct ownership by 10% to 68,085 units (SEC Form 4) (withholding obligation)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, Finance & CAO Cowan Elvia covered exercise/tax liability with 1,327 shares, decreasing direct ownership by 5% to 27,860 units (SEC Form 4) to cover taxes4 - Vaxcyte, Inc. (0001649094) (Issuer)
- EVP, Chief Scientific Ofc, COO Wassil Jim sold $163,863 worth of shares (2,715 units at $60.35) as part of a pre-agreed trading plan and covered exercise/tax liability with 5,459 shares, decreasing direct ownership by 5% to 145,435 units (SEC Form 4) (for tax liability)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Medical Officer Jodar Luis was granted 52,632 shares (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim sold $212,352 worth of shares (3,477 units at $61.07) as part of a pre-agreed trading plan, covered exercise/tax liability with 2,705 shares and exercised 2,250 shares at a strike of $5.35, decreasing direct ownership by 2% to 153,609 units (SEC Form 4) (tax withholding)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew covered exercise/tax liability with 2,705 shares, decreasing direct ownership by 3% to 102,471 units (SEC Form 4) to cover withholding tax4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 6,289 shares, decreasing direct ownership by 1% to 446,958 units (SEC Form 4) to satisfy withholding obligation4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. covered exercise/tax liability with 1,020 shares, decreasing direct ownership by 1% to 75,736 units (SEC Form 4) (withholding obligation)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, Finance & CAO Cowan Elvia covered exercise/tax liability with 569 shares, decreasing direct ownership by 2% to 29,187 units (SEC Form 4) (tax liability)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. exercised 17,000 shares at a strike of $24.79 and sold $935,068 worth of shares (17,000 units at $55.00) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim exercised 2,250 shares at a strike of $5.35 and sold $121,195 worth of shares (2,250 units at $53.86) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew exercised 10,000 shares at a strike of $5.35 and sold $538,879 worth of shares (10,000 units at $53.89) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant sold $1,012,375 worth of shares (18,198 units at $55.63) as part of a pre-agreed trading plan and exercised 16,198 shares at a strike of $2.03 (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Director Markels John4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew exercised 10,000 shares at a strike of $5.35 and sold $572,837 worth of shares (10,000 units at $57.28) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim exercised 516 shares at a strike of $5.35 and sold $126,736 worth of shares (2,250 units at $56.33) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 156,760 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant sold $1,338,270 worth of shares (24,237 units at $55.22) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 452,466 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Director Slaoui Moncef4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant exercised 225 shares at a strike of $1.79 and sold $1,284,205 worth of shares (24,461 units at $52.50) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 474,703 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew exercised 10,000 shares at a strike of $5.35 and sold $530,000 worth of shares (10,000 units at $53.00) as part of a pre-agreed trading plan (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Paya Carlos V was granted 2,265 shares, increasing direct ownership by 49% to 6,856 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Brandicourt Olivier was granted 2,194 shares, increasing direct ownership by 88% to 4,699 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Furey John was granted 2,265 shares, increasing direct ownership by 74% to 5,306 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lee Jacks was granted 2,265 shares, increasing direct ownership by 49% to 6,856 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Gilbert Halley E was granted 2,265 shares, increasing direct ownership by 22% to 12,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Loxam Teri was granted 2,265 shares, increasing direct ownership by 22% to 12,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Drapeau Anne S was granted 2,265 shares, increasing direct ownership by 22% to 12,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Lukatch Heath was granted 2,265 shares, increasing direct ownership by 13% to 19,481 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim sold $111,416 worth of shares (2,250 units at $49.52) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 158,494 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim sold $127,870 worth of shares (2,250 units at $56.83) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 160,744 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Cowan Elvia4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Wassil Jim4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Cowan Elvia4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 3,685 shares, decreasing direct ownership by 0.74% to 496,939 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SEC Form 4 filed by Vaxcyte Inc.4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, Finance & CAO Cowan Elvia covered exercise/tax liability with 569 shares, was granted 10,681 shares and exercised 7,716 shares at a strike of $25.92, increasing direct ownership by 132% to 31,362 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew was granted 44,864 shares and covered exercise/tax liability with 1,907 shares, increasing direct ownership by 69% to 105,416 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 5,394 shares and was granted 105,110 shares, increasing direct ownership by 25% to 500,624 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. was granted 53,409 shares and covered exercise/tax liability with 757 shares, increasing direct ownership by 220% to 76,580 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim was granted 37,147 shares and covered exercise/tax liability with 3,807 shares, increasing direct ownership by 24% to 175,188 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant gifted 100,000 shares, decreasing direct ownership by 20% to 400,908 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew gifted 61,850 shares and received a gift of 61,850 shares, decreasing direct ownership by 50% to 62,459 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Director Brandicourt Olivier was granted 1,357 shares, increasing direct ownership by 118% to 2,505 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. sold $454,891 worth of shares (9,743 units at $46.69), decreasing direct ownership by 29% to 23,928 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia sold $556,972 worth of shares (11,623 units at $47.92) and gifted 1,000 shares, decreasing direct ownership by 48% to 13,534 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia covered exercise/tax liability with 482 shares, decreasing direct ownership by 2% to 26,156 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. covered exercise/tax liability with 1,204 shares, decreasing direct ownership by 3% to 33,670 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF OPERATING OFFICER Wassil Jim covered exercise/tax liability with 2,759 shares, decreasing direct ownership by 2% to 141,848 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- PRESIDENT AND CFO Guggenhime Andrew covered exercise/tax liability with 2,890 shares, decreasing direct ownership by 2% to 124,309 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- CHIEF EXECUTIVE OFFICER Pickering Grant covered exercise/tax liability with 7,356 shares, decreasing direct ownership by 1% to 500,908 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- SVP, FINANCE Cowan Elvia covered exercise/tax liability with 567 shares, decreasing direct ownership by 2% to 26,638 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)
- Chief Technical Ops Officer Dhaliwal Harpreet S. covered exercise/tax liability with 1,538 shares, decreasing direct ownership by 4% to 34,874 units (SEC Form 4)4 - Vaxcyte, Inc. (0001649094) (Issuer)